1. Home
  2. DGNX vs ARDX Comparison

DGNX vs ARDX Comparison

Compare DGNX & ARDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DGNX
  • ARDX
  • Stock Information
  • Founded
  • DGNX 2018
  • ARDX 2007
  • Country
  • DGNX United Kingdom
  • ARDX United States
  • Employees
  • DGNX N/A
  • ARDX N/A
  • Industry
  • DGNX
  • ARDX Biotechnology: Pharmaceutical Preparations
  • Sector
  • DGNX
  • ARDX Health Care
  • Exchange
  • DGNX NYSE
  • ARDX Nasdaq
  • Market Cap
  • DGNX 1.1B
  • ARDX 882.9M
  • IPO Year
  • DGNX 2025
  • ARDX 2014
  • Fundamental
  • Price
  • DGNX $45.59
  • ARDX $4.32
  • Analyst Decision
  • DGNX
  • ARDX Strong Buy
  • Analyst Count
  • DGNX 0
  • ARDX 9
  • Target Price
  • DGNX N/A
  • ARDX $10.17
  • AVG Volume (30 Days)
  • DGNX 42.9K
  • ARDX 4.6M
  • Earning Date
  • DGNX 01-01-0001
  • ARDX 07-31-2025
  • Dividend Yield
  • DGNX N/A
  • ARDX N/A
  • EPS Growth
  • DGNX N/A
  • ARDX N/A
  • EPS
  • DGNX N/A
  • ARDX N/A
  • Revenue
  • DGNX $1,177,066.00
  • ARDX $361,706,000.00
  • Revenue This Year
  • DGNX N/A
  • ARDX $12.01
  • Revenue Next Year
  • DGNX N/A
  • ARDX $34.66
  • P/E Ratio
  • DGNX N/A
  • ARDX N/A
  • Revenue Growth
  • DGNX N/A
  • ARDX 127.33
  • 52 Week Low
  • DGNX $3.60
  • ARDX $3.21
  • 52 Week High
  • DGNX $155.00
  • ARDX $7.18
  • Technical
  • Relative Strength Index (RSI)
  • DGNX N/A
  • ARDX 63.34
  • Support Level
  • DGNX N/A
  • ARDX $3.49
  • Resistance Level
  • DGNX N/A
  • ARDX $4.34
  • Average True Range (ATR)
  • DGNX 0.00
  • ARDX 0.17
  • MACD
  • DGNX 0.00
  • ARDX 0.08
  • Stochastic Oscillator
  • DGNX 0.00
  • ARDX 82.35

About DGNX DIGINEX LIMITED

Diginex Ltd is an investment holding company. It engaged in providing Environmental, Social, and Governance (ESG) reporting solution services, advisory services, and developing customization solutions. It is a sustainable RegTech business that empowers businesses and governments to streamline ESG, climate, and supply chain data collection and reporting. The company utilizes blockchain, AI, machine learning, and data analysis technology to change and increase corporate regulatory reporting and sustainable finance transparency. Its solutions and services enable companies to collect, evaluate, and share sustainability data through easy-to-use software.

About ARDX Ardelyx Inc.

Ardelyx Inc is a biopharmaceutical company developing and commercialize, first-in-class medicines that meet unmet medical needs. It has developed a platform that enabled the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. It product Tenapanor, branded as IBSRELA, is used for the treatment of adults with IBS-C. Tenapanor, branded as XPHOZAH, is used to reduce serum phosphorus in adults with CKD on dialysis as add-on therapy in patients who have an inadequate response to phosphate binders or who are intolerant of any dose of phosphate binder therapy.

Share on Social Networks: